February 11, 2026 · Form 4 insider transaction
Shah Gaurav bought 286,028 shares of Rocket Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.; Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years.